Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Political Calculations (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The S&P 500 in a New Market Regime?

% of readers think this story is Fact. Add your two cents.


The S&P 500 (Index: SPX) retreated 0.3% from the previous week’s close to reach a value of 4079.09 during the trading week ending on Friday, 17 February 2023. That puts the index 15% below its record high peak of 4,796.56 set back on 3 January 2022.

Picking up where we left on in last week’s analysis, we’ve modifed our assessment for when the latest shift in the dividend futures-based model‘s multiplier occurred. We’re now looking at Friday, 6 January 2023 as the date marking when the multiplier changed from +2.0 to roughly zero, based on how stock prices behaved in the weeks leading up to and in the weeks since that date.

The latest update to the alternative futures chart shows how it looks after updating it to account for the apparent change in market regime at that time.

The question now is what changed around that time to cause the change in market regime?

The need to periodically have to answer questions like this is why we make a point of documenting the market-moving news headlines of the week. Here are the previous editions of our ongoing S&P 500 chaos series that overlap this period. Here are the relevant editions:

The biggest potential needle mover we see in the headlines over this period is the end of the Chinese government’s zero-COVID lockdowns following popular protests. Given China’s role as a major producer of goods consumed in other countries and the economic disruption its failed three-year old policy was having on global supply chains, the sudden change in its government’s policy would have global impact as details of the lifting of its lockdowns became known. Much like how the onset of 2020′s coronavirus pandemic initially triggered the first change we ever observed in real time of the dividend futures-based model’s multiplier, it would make sense that the end of the Chinese government’s economically destructive COVID response would be accompanied by another shift in the multiplier.

Before we move onto other topics, what we’ve just described is a working hypothesis that may be adapted or even dropped as we get more and better information. Stock prices are influenced by a lot of moving pieces and there are many other factors that are also at work at any given time. To filter through the noise to develop this hypothesis, we’re not just looking for the potential to cause a change in market regime, but also for factors that aren’t regularly present in the market because historical data suggests such regime changes do not happen often. We think any successful competing hypothesis would have to likewise meet that requirement.

One way we can check the hypothesis is to see what happened with expected future dividends in response to the new information. Positive dividends would be expected to arise from the end of China’s zero-COVID lockdowns and their disruptive effect on supply chains. And quite literally, they have. As touched on in the older editions of the S&P 500 chaos series highlighted above, the outlook for the S&P 500′s dividends have brightened considerably in the weeks since the market regime changed. We’ll take a closer look at when and how much they changed later this week.

Here are the market moving headlines of the week that just was, which may someday be useful to return to for reference weeks or years from now….

Monday, 13 February 2023
  • Signs and portents for the U.S. economy:
  • Egged on by economists, Fed minions say they’re ready to hike interest rates higher:
  • BOJ minions meet the new boss:
  • ECB minions identify who they see as losers:
  • Wall Street ends sharply higher as investors eye inflation data
  • Tuesday, 14 February 2023
    • Signs and portents for the U.S. economy:
  • Oil prices dip on U.S. crude reserve release, inflation pressure
  • U.S. small business sentiment improves in January – NFIB
  • Fed minions keep door open to peak policy rate above 5.1%
  • Bigger trouble developing in Eurozone:
  • Central banks expected to gear up for last rate hikes before pausing:
  • ECB minions upset by high employment:
  • Wall Street ends mixed as inflation data supports rate worries
  • Wednesday, 15 February 2023
    • Signs and portents for the U.S. economy:
  • Bigger stimulus developing in China:
  • ECB minions thinking Eurozone inflation may fall faster than they think, bigger rate hikes expected:
  • S&P 500 ends higher after strong retail sales data
  • Thursday, 16 February 2023
    • Signs and portents for the U.S. economy:
  • Fed minions want more rate hikes:
  • Bigger stimulus developing in China:
  • Central bank minions starting to put rate hikes on hold:
  • ECB minions thinking about smaller rate hikes, don’t think they’ve had much effect, may need a new plan, and worry about their credibility:
  • Wall Street ends down sharply as data fuels rate-hike worries
  • Friday, 17 February 2023
    • Signs and portents for the U.S. economy:
  • Fed minions not seeing data they want to see, say that makes them want to hike rates more:
  • Bigger stimulus causing bigger trouble in China:
  • Bigger trouble developing in the Eurozone:
  • BOJ minions have inflation, new boss to worry about:
  • ECB minions looking forward to more rate hikes and no rate cuts in 2023:
  • S&P 500 ends down as investors fret about interest rates
  • The CME Group’s FedWatch Tool continues to project a quarter point rate hike at the Fed’s upcoming 22 March (2023-Q1) meeting, followed by another at its 3 May (2023-Q2) meeting. After this week however, it now projects another quarter point rate hike at the Fed’s 14 June (2023-Q2) meeting, with rates topping out in a target range from 5.25%-5.50%. After that, the FedWatch tool anticipates the Fed will hold rates steady until 13 December 2023 (2023-Q4), when it projects a quarter point cut.

    The Atlanta Fed’s GDPNow tool‘s projection for real GDP growth in the first quarter of 2023 rose to +2.5% from its previous +2.2% estimate. The so-called “Blue Chip consensus” forecast still predicts a growth rate of less than +1.0%, and quite possibly a negative real GDP growth rate for 2023′s first quarter.



    Source: https://politicalcalculations.blogspot.com/2023/02/the-s-500-in-new-market-regime.html


    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

    Anyone can join.
    Anyone can contribute.
    Anyone can become informed about their world.

    "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


    LION'S MANE PRODUCT


    Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


    Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



    Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


    Report abuse

      Comments

      Your Comments
      Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

      MOST RECENT
      Load more ...

      SignUp

      Login

      Newsletter

      Email this story
      Email this story

      If you really want to ban this commenter, please write down the reason:

      If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.